Definium Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Definium Therapeutics, Inc. (DFTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 148.73 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2024-11-07
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2024-09-30 was 14.98K shares, a 374.03% increase year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2024-06-30 was 18.27K shares.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2024-03-31 was 115.48K shares, a 16.34% increase year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2023-12-31 was 38.74K shares, a 187.66% increase year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 103.45K shares, a 44.74% increase from fiscal 2022.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 71.48K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2024-09-30 | 14.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 33.25K shares derived: sum of 2 quarters · filed 2024-11-07 | 148.73K shares 10-Q · filed 2024-11-07 | 187.47K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 18.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 133.75K shares 10-Q · filed 2024-08-13 | 172.48K shares derived: sum of 3 quarters · filed 2024-08-13 | 175.64K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 115.48K shares 10-Q · filed 2024-05-08 | 154.22K shares derived: sum of 2 quarters · filed 2024-05-08 | 157.38K shares derived: sum of 3 quarters · filed 2024-05-08 | 119.67K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 38.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 41.90K shares derived: sum of 2 quarters · filed 2024-02-28 | 4.20K shares derived: sum of 3 quarters · filed 2024-02-28 | 103.45K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 3.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -34.54K shares derived: sum of 2 quarters · filed 2023-11-02 | 64.72K shares 10-Q · filed 2023-11-02 | 78.19K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | -37.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 61.56K shares 10-Q · filed 2023-08-03 | 75.02K shares derived: sum of 3 quarters · filed 2023-08-03 | -463.51K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 99.26K shares 10-Q · filed 2023-05-04 | 112.73K shares derived: sum of 2 quarters · filed 2023-05-04 | -425.81K shares derived: sum of 3 quarters · filed 2023-05-04 | |
| 2022-12-31 | 13.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -525.07K shares derived: sum of 2 quarters · filed 2023-03-09 | 71.48K shares 10-K · filed 2023-03-09 | |
| 2022-09-30 | -538.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 58.01K shares 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | 596.55K shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |